News
Aeries Technology Swings to Q1 Profit
Aeries Technology (NASDAQ:AERT), a business services provider focused on Global Capability Centers (GCCs) and AI-driven transformation for private equity-backed clients, reported its Q1 FY2026
AFC Gamma Posts Q2 Loss and 73% EPS Drop
AFC Gamma (NASDAQ:AFCG), a specialty lender focused on the cannabis sector, reported its earnings for the second quarter of fiscal 2025 on August 14, 2025. The company recorded distributable
Lm Funding America Posts Q2 Profit Swing
Lm Funding America (NASDAQ:LMFA), a company primarily focused on Bitcoin mining and association funding solutions, released its earning results for the second quarter of fiscal 2025 on August 14
Qxo Posts 1,906 Million Revenue in Q2
Qxo (NYSE:QXO), a rapidly transforming distributor of building products, released its second quarter earnings for fiscal 2025 on August 14, 2025. The most notable news was that it recorded Adjusted
3 Reasons XRP Is Surging Right Now
When investors think they can finally see the market's road ahead, they tend to step on the gas. That's what is happening now to XRP (CRYPTO: XRP) this summer, with the coin's price rising by 33% in
SpartanNash Posts 46% Profit Drop in Q2
SpartanNash (NASDAQ:SPTN), a major grocery wholesaler and retailer, released its second quarter results for fiscal 2025 on August 14, 2025. The big story from the release was stronger-than-expected
Cellectar Cuts Q2 Losses and Expenses
Cellectar Biosciences (NASDAQ:CLRB), a biotechnology company specializing in targeted cancer therapies, delivered its latest earnings results for the second quarter of fiscal 2025 on August 14
reAlpha Tech Sales Jump 1,909 Percent
reAlpha Tech (NASDAQ:AIRE), a real estate technology company focused on AI-driven mortgage and property services, posted its fiscal second quarter 2025 earnings on August 14, 2025. Driven by rapid
Abeona Posts Q2 Profit on Asset Sale
Abeona Therapeutics (NASDAQ:ABEO), a biotechnology company focused on developing and commercializing cell and gene therapies for rare diseases, reported its second quarter 2025 earnings on August
Is This a Sign Opendoor Technologies Is on the Right Track?
Opendoor Technologies (NASDAQ: OPEN) has been one of the hottest meme stocks to own of late. It was just a month ago that shares were trading at less than $1, and they have more than doubled in
FitLife Brands Reports 5 Percent Q2 Drop
FitLife Brands (NASDAQ:FTLF), a nutritional supplements company with products spanning sports nutrition, weight management, and general wellness, released its financial results for the second
Palvella Posts Cash Gain and Trial Wins
Palvella Therapeutics (NASDAQ:PVLA), a late-stage biopharmaceutical company focused on rare genetic skin diseases, released second-quarter 2025 earnings results on August 14, 2025. No revenue was
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Ibotta Q2 Revenue Falls Short
Ibotta(NYSE:IBTA) reported second quarter 2025 earnings on August 13, 2025, with revenue of $86 million, a 2% year-over-year decline, and adjusted EBITDA of $17.9 million. Management cited a 48%
Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc
Larimar Beats Q2 Loss Estimates
Larimar Therapeutics (NASDAQ:LRMR), a clinical-stage biotechnology firm focused on treatments for rare diseases such as Friedreich’s ataxia, reported its second quarter results on August 14, 2025
Atai Life Sciences Revenue Jumps 163%
Atai Life Sciences (NASDAQ:ATAI), a biotechnology company developing novel treatments for mental health conditions, reported its results for the second quarter of fiscal 2025 on August 14, 2025. The
Should You Buy UPS While It's Below $90?
United Parcel Service (NYSE: UPS) is back in the bargain bit. As of this writing, shares of the package shipping company trade under $90, a level they haven't seen since before the COVID-fueled
Hyperfine Q2 Revenue Jumps 26 Percent
Hyperfine reported second quarter 2025 results on Aug. 13, highlighting $2.7 million in revenue for the first half of the year, a 26% sequential increase, and the sale of eight systems in the second
Werewolf Reports No Revenue in Fiscal Q2
Werewolf Therapeutics (NASDAQ:HOWL), an early-stage biotechnology company dedicated to innovative cancer immunotherapies, reported its second quarter 2025 results on August 14, 2025. The main story
Accuray Q4 Revenue Hits $128 Million
Accuray reported fourth-quarter fiscal 2025 results on August 13, 2025, with $128 million in revenue (down 5% year-over-year), service revenue of $56.9 million (up 4% year-over-year), and adjusted
Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc
Prelude Cuts Q2 Losses and Costs 13%
Prelude Therapeutics (NASDAQ:PRLD), a clinical-stage precision oncology company concentrating on novel cancer therapies, released its second quarter 2025 earnings on August 14, 2025. The headline
Leap Therapeutics Slashes R&D Spending
Leap Therapeutics (NASDAQ:LPTX), a clinical-stage biotechnology company focused on cancer therapies, released its second quarter 2025 results on August 14, 2025. The company reported a net loss of
Bk Technologies EPS Jumps 136 Percent
Bk Technologies (NYSEMKT:BKTI), a public safety radio and communications equipment provider, released its second quarter fiscal 2025 results on August 14, 2025. The company posted a major earnings